摘要 |
<p>It is intended to provide compounds effective in the prevention, treatment or improvement of a disease in which a thrombopoietin receptor activation action is effective. A compound represented by the formula (I) (wherein, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, L<SUP>1</SUP>, L<SUP>2</SUP>, L<SUP>3</SUP>, X and Y are defined in the description), an interchangeable isomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a solvate thereof.</p> |
申请人 |
NISSAN CHEMICAL INDUSTRIES, LTD.;MIYAJI, KATSUAKI;IWAMOTO, SHUNSUKE;SHIGETA, YUKIHIRO;HIROKAWA, YUTAKA;OOWADA, SHINGO;NAKAMURA, TAKANORI;ISHIWATA, NORIHISA |
发明人 |
MIYAJI, KATSUAKI;IWAMOTO, SHUNSUKE;SHIGETA, YUKIHIRO;HIROKAWA, YUTAKA;OOWADA, SHINGO;NAKAMURA, TAKANORI;ISHIWATA, NORIHISA |